NCT04720326: Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients |
|
|
| Active, not recruiting | 4 | 268 | Europe | Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf | Edward Geissler, Chiesi Pharmaceuticals GmbH, Excelya | Prophylaxis Against Liver Transplant Rejection | 01/24 | 10/26 | | |
| Not yet recruiting | N/A | 4500 | Europe | | Assistance Publique - Hôpitaux de Paris, European Society for Organ Transplantation (ESOT)-European Liver and Intestine Transplant Association (ELITA)ELITA, University Luxembourg (UNILU) - ELIXIR, Italian National Transplant Centre (CNT), La Fe University hospital Valencia (HULAFE) | Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma | 12/27 | 11/28 | | |
| Not yet recruiting | N/A | 630 | Europe | Standardized assessments, guided tumor biopsy and biobanking, Standardized assessments and biobanking | Assistance Publique - Hôpitaux de Paris, University Luxembourg (UNILU) - ELIXIR, Hospital Universitario La Fe, ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (ECRIN), Ophiomics - Precision Medicine, EF CLIF, INSERM 1149, INSERM U1052 | Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma | 01/27 | 10/27 | | |
